Stay updated on Savolitinib Combo in EGFRm+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:31:38.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:32:30.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the prior study content with a standard error screen. This prevents viewing the study details from the ClinicalTrials.gov entry.
    Difference
    19%
    Check dated 2026-09-20T20:35:31.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page shows a revision label update from v3.6.5 to v3.6.6, which appears to be a non-substantive page update and does not alter the study details or eligibility.
    Difference
    0.0%
    Check dated 2026-08-30T22:27:23.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The study record now includes data-sharing information (IPD Sharing URL, plan, access criteria) and added study documents (SAP, CSP, CSR, PDFs) along with sponsor-related resources and keywords. A prior error placeholder was replaced by actual content.
    Difference
    67%
    Check dated 2026-08-16T16:50:39.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page shows a new revision tag: v3.6.5, replacing the previous v3.6.4. This appears to be a software update to the page rather than a change to the trial information.
    Difference
    0.0%
    Check dated 2026-08-09T10:59:50.000Z thumbnail image

Stay in the know with updates to Savolitinib Combo in EGFRm+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.